Furthermore, we elucidated the mechanism of gracillin’s benefits against gastric carcinoma: that gracillin inhibits cell proliferation involving the PI3K/AKT pathway and cell cycle arrest, suppresses the EMT pathway to regulate cell migration, and induces bcl2-associated mitochondrial apoptosis. The gene discussed is AKT1; the disease is gastric carcinoma.